Investor Corner
Concord Biotech Limited is dedicated to fostering transparent relationships with its investors, delivering timely updates, and sharing key insights into its business growth. With a focus on biotechnology innovation and financial accountability, Concord aims to keep investors informed and engaged in its journey toward impactful advancements and global success.
Financial Information
Dividend Details
Unclaimed and Unpaid Dividend
IEPF
Stock Exchange Disclosures
Disclosures Under Regulation 46 of LODR
ESG Report
Investors Contact
Contact details of the Investor Relations (including, for grievances)
| Name of Key Managerial Personnel | Designation | Telephone No. | Email Id |
|---|---|---|---|
| Mr. Lalit Sethi | Chief financial officer | +91 74860 23290 | lalitsethi@concordbiotech.com | Ms Hina Patel | Company Secretary and Compliance Officer | +91 079 68138700 | complianceofficer@concordbiotech.com |
Registrar and Transfer Agent
Contact Details
MUFG Intime India Private Limited